VC-backed Mirna Therapeutics debuts IPO
Austin, Texas-based Mirna Therapeutics Inc, a biopharmaceutical company focused on developing cancer-treating drugs, has raised almost $44 million for its IPO after pricing its 6.25 million shares at $7 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "MIRN." Citigroup and Leerink Partners are the lead underwriters. Mirna's backers included Sofinnova Ventures, New Enterprise Associates, Pfizer Ventures, Osage University Partners and Correlation Ventures.
1 October 2015•3 mins read
